Is surgical treatment effective option for survival of small cell lung cancer?
Journal Title: Current Thoracic Surgery - Year 2018, Vol 3, Issue 3
Abstract
Background: Small cell lung cancer (SCLC) accounts for 10% of all lung cancers. Due to the fact that it is an aggressive tumor, there is still no consensus on treatment. Our aim in this study was to evaluate prognostic factors affecting survival in early-stage small cell lung cancer. Materials and Methods: Between 2008 and 2017, 21 patients who underwent resection due to earlystage SCLC were evaluated retrospectively in the study. 16 (76.2%) stage I and 5 (23.8%) stage II patients were included in the study. All patients received adjuvant therapy after surgery. Results: Sixteen (76.2%) male and 5 (23.8) female patients were included in the study. The mean age was 60.19 ± 7.13 years. Patients were followed for a mean of 33 months. There was 16 (76.2%) small cell, and 5 (23.6%) combined small cell carcinoma. The 5-year survival rate was 48.6% (59.6 ± 10.6 months). In 7 patients (33.3%) postoperative morbidity was observed. No statistically significant difference was found between N status and survival. Statistically significant differences were found between tumors smaller than 1 cm and tumors greater than 1 cm in terms of T stage (p = 0.043). Conclusions: In conclusion, multimodal treatment is very important for survival in early-stage small cell lung cancer. Although our results in our study are aggressive tumors of the SCLC, survival outcomes in the early stages are quite satisfactory. Early stage survival outcomes, especially after stage I tumors, are as successful as non-small cell lung cancers.
Authors and Affiliations
Celal Buğra Sezen, Umut Kilimci, Oğuz Girgin, Yunus Aksoy, Ozkan Saydam, Seyyit İbrahim Dincer, Muzaffer Metin
Keywords
Related Articles
- EP ID EP517477
- DOI 10.26663/cts.2019.00021
- Views 75
- Downloads 0
Laparoscopic Heller myotomy is equally efficient and safe in patients who had pre-myotomy endoscopic interventions when compared with those with no intervention.
Background: Endoscopic treatment (ET) methods for achalasia such as balloon dilatation and botulinum toxin injection has good success for short and medium term management of achalasia. However some patients either need r...
Pulmonary congenital cystic adenomatoid malformation accompanied with hamartoma in an adult: report of a case
Congenital cystic adenomatoid malformation (CCAM) is mostly recognized in children and adult presentation is rare. Here, a 42-year-old male patient was presented. He had a previous history of pneumothorax, and radiologic...
Comparison of the outcomes of the implanted subcutaneous ports in cancer patients: six-years single center experience
Background: The preferred site of venous access ranges from deep veins (internal jugular or subclavian veins) to superficial veins (external jugular, anterior jugular, and upper limb veins). The aim of the study is to e...
Adult congenital lobar emphysema treated with video-assisted thoracoscopic lobectomy
Congenital lobar emphysema (CLE) is a rare developmental anomaly of the lower respiratory tract, which generally presents during the neonatal/pediatric period. Lobectomy is the only curative treatment for CLE. An 18-year...
Isolated giant chest wall metastasis of papillary thyroid carcinoma; case report
Pulmonary metastases of papillary thyroid carcinoma (PTC) is rare and generally present as a micronodular or a miliary pattern. Herein we present a single giant chest wall metastasis of PTC that caused mediastinal shift...